The live activity will feature a series of didactic presentations coupled with case-based panel discussions and question-and-answer sessions from the audience. Using a blended instructional model of didactic presentations and interactive panel discussions is intended is to improve medical practices and patient care through evidence-based presentations, discussion, and authoritative peer-exchange on important clinical issues. The satellite program will bring together 4 clinical experts to highlight novel agents in the management of ALL/LBL, including the latest clinical data and application of asparaginase formulations across the ALL continuum, including best practices for monitoring and managing hypersensitivity and silent inactivation reactions in the United States and around the world! Considerations for advanced practice professionals and community clinicians will also be addressed throughout the educational event.